Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $106.83M | $170.69M | 26.19% | +$63.86M |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $110.19M | $125.85M | 19.31% | +$15.66M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $110.74M | $113.13M | 17.36% | +$2.39M |
| Lyell Immunopharma, Inc.(LYEL) | 2,759,072 | 2,759,072 | 0 | $44.81M | $84.92M | 13.03% | +$40.12M |
| Vir Biotechnology, Inc.(VIR) | 12,916,663 | 12,916,663 | 0 | $73.75M | $77.89M | 11.95% | +$4.13M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $24.10M | $41.13M | 6.31% | +$17.03M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $21.19M | $24.97M | 3.83% | +$3.79M |
| 10x Genomics, Inc.CL A(TXG) | 0 | 737,539 | +737,539 | $0 | $12.03M | 1.85% | +$12.03M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $634.6K | $1.06M | 0.16% | +$429.4K |
| Cero Therapeutics Holdings Inc. | 22,389 | 0 | -22,389 | $114.0K | $0 | — | -$114.0K |